COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 169 filers reported holding COHERUS BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $55,762 | -38.7% | 13,059 | -1.8% | 0.00% | 0.0% |
| Q1 2023 | $90,924 | -15.1% | 13,293 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $107,150 | -12.9% | 13,529 | +5.4% | 0.00% | -50.0% |
| Q3 2022 | $123,000 | +57.7% | 12,835 | +18.9% | 0.00% | +100.0% |
| Q2 2022 | $78,000 | -96.5% | 10,793 | -93.8% | 0.00% | -95.8% |
| Q1 2022 | $2,241,000 | +5.4% | 173,615 | +30.3% | 0.02% | +9.1% |
| Q4 2021 | $2,127,000 | -1.3% | 133,242 | -0.7% | 0.02% | +4.8% |
| Q3 2021 | $2,156,000 | +13.8% | 134,165 | -2.1% | 0.02% | +10.5% |
| Q2 2021 | $1,895,000 | -8.4% | 136,992 | -3.2% | 0.02% | -13.6% |
| Q1 2021 | $2,068,000 | -19.8% | 141,552 | -4.5% | 0.02% | -24.1% |
| Q4 2020 | $2,577,000 | +45.3% | 148,255 | +53.3% | 0.03% | +20.8% |
| Q3 2020 | $1,774,000 | +3247.2% | 96,704 | +3174.8% | 0.02% | +2300.0% |
| Q2 2020 | $53,000 | – | 2,953 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |